全球精準診斷市場規模、佔有率、趨勢及成長分析報告（2026-2034）

預計精準診斷市場將從 2025 年的 235.5 億美元成長到 2034 年的 1,123.5 億美元，2026 年至 2034 年的複合年成長率為 18.96%。

隨著醫療保健系統向個人化醫療和標靶治療模式轉變，全球精準診斷市場正在快速成長。精準診斷利用基因檢測、分子診斷和生物標記分析等先進技術，更準確地識別疾病。這些工具能夠幫助醫生為每位患者選擇最有效的治療方法。

市場成長的主要促進因素之一是癌症和遺傳性疾病等慢性病盛行率的不斷上升。醫療服務提供者正在採用先進的診斷工具來早期發現疾病並制定個人化的治療方案。生物技術研發和基因組學領域投資的不斷增加也推動了市場成長。

隨著醫療保健產業向個人化和數據驅動的治療策略轉變，精準診斷市場預計將顯著成長。基因測序、人工智慧和數位健康技術的進步將提高診斷準確性。隨著醫療服務提供者越來越重視早期檢測和精準醫療，對先進診斷解決方案的需求將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球精準診斷市場：依類型分類

• 市場分析、洞察與預測
• 基因檢測
• 消費者測試
• 特殊檢查
• 其他

第5章 全球精準診斷市場：依應用分類

• 市場分析、洞察與預測
• 腫瘤學
• 呼吸系統疾病
• 皮膚病
• 中樞神經系統疾病
• 免疫學
• 遺傳性疾病
• 其他

第6章：全球精準診斷市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 臨床檢查室
• 其他

第7章 全球精準診斷市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories
  • F. Hoffmann-La Roche Ltd
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc
  • BioMerieux SA
  • Becton, Dickinson And Company
  • Danaher Corporation
  • QIAGEN NV
  • Hologic Inc
  • Agilent Technologies Inc

The Precision Diagnostics Market size is expected to reach USD 112.35 Billion in 2034 from USD 23.55 Billion (2025) growing at a CAGR of 18.96% during 2026-2034.

The global precision diagnostics market is growing rapidly as healthcare systems focus on personalized medicine and targeted treatment approaches. Precision diagnostics involves using advanced technologies such as genetic testing, molecular diagnostics, and biomarker analysis to identify diseases more accurately. These tools help doctors select the most effective treatments for individual patients.

One of the major drivers of the market is the increasing prevalence of chronic diseases such as cancer and genetic disorders. Healthcare providers are adopting advanced diagnostic tools to detect diseases at an early stage and develop personalized treatment plans. Growing investments in biotechnology research and genomic technologies are also supporting market expansion.

In the future, the precision diagnostics market is expected to expand significantly as healthcare moves toward personalized and data-driven treatment strategies. Advances in genomic sequencing, artificial intelligence, and digital health technologies will improve diagnostic accuracy. As healthcare providers focus more on early detection and precision medicine, demand for advanced diagnostic solutions will continue to rise.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Genetic Tests
• Direct to Consumer Tests
• Esoteric Tests
• Others

By Application

• Oncology
• Respiratory Diseases
• Skin Diseases
• CNS Disorders
• Immunology
• Genetic Diseases
• Others
• By-End-use
• Hospitals
• Clinical Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories, F HoffmannLa Roche Ltd, Siemens Healthineers AG, Thermo Fisher Scientific Inc, bioMrieux SA, Becton, Dickinson and Company, Danaher Corporation, QIAGEN NV, Hologic Inc, Agilent Technologies Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRECISION DIAGNOSTICS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Genetic Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Direct to Consumer Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Esoteric Tests Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRECISION DIAGNOSTICS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Respiratory Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Skin Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. CNS Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Immunology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. Genetic Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRECISION DIAGNOSTICS MARKET: BY BY-END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast By-end-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Clinical Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL PRECISION DIAGNOSTICS MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type
  • 7.2.2 By Application
  • 7.2.3 By By-end-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type
  • 7.3.2 By Application
  • 7.3.3 By By-end-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type
  • 7.4.2 By Application
  • 7.4.3 By By-end-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type
  • 7.5.2 By Application
  • 7.5.3 By By-end-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type
  • 7.6.2 By Application
  • 7.6.3 By By-end-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL PRECISION DIAGNOSTICS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories
  • 9.2.2 F. Hoffmann-La Roche Ltd
  • 9.2.3 Siemens Healthineers AG
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 BioMerieux SA
  • 9.2.6 Becton, Dickinson And Company
  • 9.2.7 Danaher Corporation
  • 9.2.8 QIAGEN N.V
  • 9.2.9 Hologic Inc
  • 9.2.10 Agilent Technologies Inc